rp 73401 has been researched along with bay 58-2667 in 1 studies
| Studies (rp 73401) | Trials (rp 73401) | Recent Studies (post-2010) (rp 73401) | Studies (bay 58-2667) | Trials (bay 58-2667) | Recent Studies (post-2010) (bay 58-2667) |
|---|---|---|---|---|---|
| 92 | 0 | 23 | 104 | 6 | 69 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunkern, TR; Feurstein, D; Hatzelmann, A; Rossi, GA; Sabatini, F | 1 |
1 other study(ies) available for rp 73401 and bay 58-2667
| Article | Year |
|---|---|
Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
Topics: Actins; Benzamides; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Cyclic GMP; Dinoprostone; Drug Synergism; Enzyme Activators; Fibroblasts; Fibrosis; Guanylate Cyclase; Humans; Immunohistochemistry; Isoenzymes; Lung; Myocytes, Smooth Muscle; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Transforming Growth Factor beta | 2007 |